Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

GSK (GSK) News Today

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free GSK Stock Alerts
GBX 1,777.50
+2.50 (+0.14%)
(As of 08:32 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability
May 16, 2024 | lse.co.uk
TOP NEWS: GSK to sell remaining holding in spin-off Haleon
May 16, 2024 | msn.com
GSK to sell entire Haleon stake
May 15, 2024 | msn.com
GSK chief calls for more investment to combat drug-resistant bacteria
May 14, 2024 | finanznachrichten.de
The Department of Health - Abu Dhabi: Department of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution Hub
May 14, 2024 | finance.yahoo.com
Department of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution Hub
May 14, 2024 | americanbankingnews.com
GSK (LON:GSK) Sets New 1-Year High at $1,821.00
May 10, 2024 | americanbankingnews.com
GSK (LON:GSK) Reaches New 1-Year High at $1,767.50
May 9, 2024 | forbes.com
Buy Write Grabs Next Week’s Dividend From GSK
May 9, 2024 | finance.yahoo.com
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
May 8, 2024 | marketbeat.com
GSK (LON:GSK) Reaches New 12-Month High at $1,767.50
GSK (LON:GSK) Sets New 12-Month High at $1,767.50
May 7, 2024 | marketbeat.com
GSK's (GSK) Equal Weight Rating Reiterated at Barclays
Barclays reiterated an "equal weight" rating and issued a GBX 1,725 ($21.67) price objective on shares of GSK in a research report on Tuesday.
May 6, 2024 | finance.yahoo.com
GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
May 5, 2024 | finance.yahoo.com
GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
May 2, 2024 | bloomberg.com
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
May 2, 2024 | msn.com
Moderna to seek parity for RSV shot as rivals lead in market
May 2, 2024 | marketbeat.com
GSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted their price objective on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an "underweight" rating in a research note on Thursday.
May 2, 2024 | marketbeat.com
GSK (LON:GSK) Sets New 1-Year High After Dividend Announcement
GSK (LON:GSK) Sets New 12-Month High After Dividend Announcement
May 1, 2024 | marketbeat.com
GSK plc (LON:GSK) to Issue GBX 15 Dividend
GSK plc (LON:GSK) declared a dividend on Wednesday, May 1st. Investors of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share on Thursday, July 11th. This represents a yield of 0.9%. The ex-dividend date of this dividend is Thursday, May 16th. The official announcement can be seen at this link.
May 1, 2024 | marketbeat.com
GSK (LON:GSK) Earns Buy Rating from Shore Capital
Shore Capital reiterated a "buy" rating on shares of GSK in a report on Wednesday.
May 1, 2024 | morningstar.com
GSK Lifts Guidance After Turnover Beats Expectations — Update
May 1, 2024 | msn.com
GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; updates FY24 outlook
April 30, 2024 | finance.yahoo.com
Genomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design
April 30, 2024 | marketwatch.com
GSK Turnover, Net Profit Expected to Rise as Investors Seek Zantac Litigation Clarity -- Earnings Preview
April 24, 2024 | msn.com
SCI, GSK launches $1m initiative to boost immunisation rate in Nigeria, Ethiopia
April 24, 2024 | msn.com
US regulator accepts GSK’s application to expand treatment of cancer drug
April 24, 2024 | ft.com
GSK readies for pivotal ruling in Zantac cases
April 19, 2024 | seekingalpha.com
GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve
April 18, 2024 | finance.yahoo.com
GSK Canada expands charitable partnerships to include support of environmental sustainability and STEM
April 17, 2024 | marketbeat.com
Deutsche Bank Aktiengesellschaft Reaffirms "Buy" Rating for GSK (LON:GSK)
Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 1,950 ($24.27) target price on shares of GSK in a research note on Wednesday.
April 16, 2024 | finance.yahoo.com
GSK May 2024 28.000 call (GSK240517C00028000)
April 16, 2024 | seekingalpha.com
Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts
April 16, 2024 | finance.yahoo.com
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
April 16, 2024 | lse.co.uk
GSK's latest meningitis vaccine accepted for review by US regulator
April 16, 2024 | markets.businessinsider.com
FDA Accepts GSK's 5-in-1 Meningococcal ABCWY Vaccine Candidate For Regulatory Review
April 14, 2024 | marketbeat.com
GSK plc (LON:GSK) Given Average Rating of "Hold" by Analysts
Shares of GSK plc (LON:GSK - Get Free Report) have earned a consensus rating of "Hold" from the seven brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given
April 12, 2024 | finance.yahoo.com
GSK plc: GSK's Strong Vaccine and HIV Portfolios Support Steady Growth
April 11, 2024 | msn.com
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
April 11, 2024 | msn.com
Democrats push more drug makers to lower the price of inhalers
April 11, 2024 | forbes.com
Will Biopharma Companies Shun Vaccine R&D In A New Pandemic?
April 8, 2024 | marketbeat.com
GSK (LON:GSK) Earns "Equal Weight" Rating from Barclays
Barclays reissued an "equal weight" rating and issued a GBX 1,725 ($21.65) target price on shares of GSK in a research note on Monday.
April 3, 2024 | marketbeat.com
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment (GSK)
Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia
April 2, 2024 | markets.businessinsider.com
Buy Rating Affirmed for SCYNEXIS on Ibrexafungerp Success and Strong GSK Partnership
April 2, 2024 | seekingalpha.com
Scynexis: Update Following Restructuring Of GSK Deal
April 2, 2024 | seekingalpha.com
Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade)
March 28, 2024 | bizjournals.com
Former GSK office building in Navy Yard set for sheriff's sale to satisfy $78M foreclosure judgment
March 23, 2024 | insidertrades.com
Insider Buying: GSK plc (LON:GSK) Insider Buys 434 Shares of Stock
March 22, 2024 | marketbeat.com
GSK plc (LON:GSK) Insider Buys £7,213.08 in Stock
GSK plc (LON:GSK - Get Free Report) insider Urs Rohner bought 434 shares of the business's stock in a transaction that occurred on Wednesday, March 20th. The shares were acquired at an average price of GBX 1,662 ($21.16) per share, with a total value of £7,213.08 ($9,182.79).
March 21, 2024 | benzinga.com
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
March 20, 2024 | markets.businessinsider.com
Sosei Regains Full Ownership From GSK Of Clinic-Ready GPR35 Agonist For Inflammatory Bowel Disease
March 20, 2024 | reuters.com
GSK to cap out-of-pocket inhaler costs in US
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment
▼
0.12

0.42
▲
Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week
▼
6

7
▲
GSK Articles
Average Week

Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (LON:GSK) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Urgent Nvidia Warning
Altimetry
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Global crypto currency reset (41 major banks signed up)
Stansberry Research
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing